Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study.

MLA

Godtfredsen, Sissel J., et al. “Effectiveness and Safety of P2Y12 Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Nationwide Registry-Based Study.” European Heart Journal. Acute Cardiovascular Care, vol. 11, no. 9, Sept. 2022, pp. 697–705. EBSCOhost, https://doi.org/10.1093/ehjacc/zuac095.

APA

Godtfredsen, S. J., Kragholm, K. H., Leutscher, P., Jørgensen, S. H., Christensen, M. K., Butt, J. H., Gislason, G., Køber, L., Fosbøl, E. L., Sessa, M., Bhatt, D. L., Torp-Pedersen, C., & Pareek, M. (2022). Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study. European Heart Journal. Acute Cardiovascular Care, 11(9), 697–705. https://doi.org/10.1093/ehjacc/zuac095

Chicago

Godtfredsen, Sissel J, Kristian H Kragholm, Peter Leutscher, Steen Hylgaard Jørgensen, Martin Kirk Christensen, Jawad H Butt, Gunnar Gislason, et al. 2022. “Effectiveness and Safety of P2Y12 Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Nationwide Registry-Based Study.” European Heart Journal. Acute Cardiovascular Care 11 (9): 697–705. doi:10.1093/ehjacc/zuac095.